The influence of THC:CBD oromucosal spray on driving ability in patients with multiple sclerosis‐related spasticity
Abstract Background: Driving ability is a key function for the majority of patients with multiple sclerosis (MS) to help maintain…
sativex
The role of Sativex in robotic rehabilitation in individuals with multiple sclerosis
Abstract Introduction: Currently, none of the available multiple sclerosis (MS) disease-modifying medications has been shown to stop or reverse gait…
A randomised controlled cross-over double-blind pilot study protocol on THC:CBD oromucosal spray efficacy as an add-on therapy for post-stroke spasticity
Abstract Introduction: Stroke is the most disabling neurological disorder and often causes spasticity. Transmucosal cannabinoids (tetrahydrocannabinol and cannabidiol (THC:CBD), Sativex)…
A Phase I, open-label, randomized, crossover study in three parallel groups to evaluate the effect of Rifampicin, Ketoconazole, and Omeprazole on the pharmacokinetics of THC/CBD oromucosal spray in healthy volunteers
Abstract Abstract: This Phase I study aimed to assess the potential drug-drug interactions (pharmacokinetic [PK] and safety profile) of Δ9-tetrahydrocannabinol…